The role of interleukin-8 and its receptors in inflammatory lung disease: Implications for therapy

American Journal of Respiratory Medicine

Volumn 1, Issue 1, 2002, Pages 19-25

  Pease, James E ^a   Sabroe, Ian ^a  

^a Faculty of Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA CHEMOKINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CORTICOSTEROID; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; AUTOREGULATION; BINDING AFFINITY; CELL SURFACE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DRUG STRUCTURE; DRUG TARGETING; GENE CONTROL; GENE EXPRESSION; HUMAN; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING; RESPIRATORY DISTRESS SYNDROME; REVIEW; SAMPLE;

EID: 0042387838     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03257159     Document Type: Review

References (85)

1. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-42
2. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145-76
3. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-4
4. Kelner GS, Kennedy J, Bacon KB, et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994; 266: 1395-9
5. Clore GM, Appella E, Yamada M, et al. Three-dimensional structure of interleukin 8 in solution. Biochemistry 1990; 29: 1689-96
6. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-23
7. Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000 Jan; 28 (1): 235-42
8. Yoshimura T, Matsushima K, Tanaka S, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7
9. Schroder JM, Mrowietz U. Morita E, et al. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474-83
10. Walz A, Peveri P, Aschauer H, et al. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Common 1987; 149: 755-61
11. Beaubien BC, Collins PD, Jose PJ, et al. A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo: purification, partial amino acid sequence and structural relationship to interleukin 8. Biochem J 1990; 271: 797-801
12. Jose PJ, Collins PD, Perkins JA, et al. Identification of a second neutrophil chemoattractant cytokine generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo: purification, partial amino acid sequence and structural relationship to melanoma growth stimulatory activity. Biochem J 1991; 278: 493-7
13. Clark-Lewis I, Schumacher C, Baggiolini M, et al. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis. exocytosis, and receptor binding activities. J Biol Chem 1991; 266: 23128-34
14. Braun RK, Franchini M, Erard F, et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 1993; 23: 956-60
15. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996; 156: 4859-66
16. Strieter RM, Phan SH, Showell HJ, et al. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989; 264: 10621-6
17. Strieter RM, Chensue SW, Basha MA, et al. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol 1990; 2: 321-6
18. Nakamura H, Yoshimura K, Jaffe HA, et al. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991; 266: 19611-7
19. Blease K, Chen Y, Hellewell PG, et al. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells. J Immunol 1999; 163: 6139-47
20. John M, Au B-T, Jose PJ, et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 1998; 18: 84-90
21. Schnyder-Candrian S, Walz A. Neutrophil-activating protein ENA-78 and IL-8 exhibit different patterns of expression in lipopolysaccharide- and cytokine-stimulated human monocytes. J Immunol 1997; 158: 3888-94
22. Standiford TJ, Strieter RM, Chensue SW, et al. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 1990; 145: 1435-9
23. de Waal M, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-20
24. Monsinjon T, Gasque P, Ischenko A, et al. C3 A binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8. FEBS Lett 2001 Jan; 487 (3): 339-46
25. Wang W, Tanaka T, Okamura H, et al. Interleukin-18 enhances the production of interleukin-8 by eosinophils. Eur J Immunol 2001 Apr; 31 (4): 1010-6
26. Kwon OJ, Au BT, Collins PD, et al. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 1994; 81: 389-94
27. Miyamasu M, Misaki Y, Izumi S, et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 1998; 101: 75-83
28. Mukaida N, Okamoto S, Ishikawa Y, et al. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56: 554-8
29. Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994; 269: 13289-95
30. Holmes WE, Lee J, Kuang W-J, et al. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278-83
31. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-3
32. Ahuja SK, Lee JC, Murphy PM. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B: Determinants of high affinity binding and receptor activation are distinct. J Biol Chem 1996; 271: 225-32
33. Salcedo R, Resau JH, Halverson D, et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000; 14: 2055-64
34. Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1094-103
35. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: Possible functions of each receptor. J Immunol 1995; 155: 2587-94
36. Venuprasad K. Parab P, Prasad DV, et al. Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression. Eur J Immunol 2001 May; 31 (5): 1536-43
37. Mitchell GB, Khandaker MH, Rahimpour R, et al. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes. Eur J Immunol 1999; 29: 1467-76
38. Wenzel SE, Szefler SJ, Leung DY, et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156: 737-43
39. Atkins PC, Norman M, Weiner H, et al. Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. Ann Intern Med 1977; 86: 415-8
40. Lee TH, Nagakura T. Papageorgiou N, et al. Exercise-induced late asthmatic reactions with neutrophil chemotactic activity. N Engl J Med 1983; 308: 1502-5
41. Shute JK, Vrugt B, Lindley IJ, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997; 6: 1877-83
42. Jatakanon A, Lalloo UG, Lim S, et al. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999: 54: 234-7
43. Pavord ID, Brightling CE. Woltmann G. et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-4
44. Tang RB, Chen SJ. Evaluation of serum interleukin-8 as a marker of disease activity in acute asthma in children. J Asthma 2000; 37: 409-13
45. Ordonez CL, Shaughnessy TE, Matthay MA, et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000 Apr; 161 (4 Pt 1): 1185-90
46. Gibson PG, Simpson JL. Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001 May; 119 (5): 1329-36
47. Kurashima K, Mukaida N, Fujimura M, et al. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996; 59: 313-6
48. Korn SH, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001; 17: 1070-7
49. Marini M, Vittori E, Hollemborg J, et al. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89: 1001-9
50. Yousefi S, Hemmann S, Weber M, et al. IL-8 is expressed by human peripheral blood cosinophils. Evidence for increased secretion in asthma. J Immunol 1995: 154: 5481-90
51. Simon HU, Yousefi S, Weber M, et al. Human peripheral blood eosinophils express and release interleukin-8. Int Arch Allergy Immunol 1995; 107: 124-6
52. Kita H, Abu-Ghazaleh RI, Sur S, et al. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 1995; 154: 4749-58
53. Page SM, Gleich GJ. Roebuck KA, et al. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 1999; 21: 230-7
54. Sehmi R, Cromwell O. Wardlaw AJ, et al. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993; 23: 1027-36
55. Lampinen M, Rak S, Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 1999; 29: 314-22
56. Warringa RA, Mengelers HJ, Raaijmakers JA, et al. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993; 91: 1198-205
57. Sabroe I, Hartnell A, Jopling LA, et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 1999; 162: 2946-55
58. Petering H. Gotze O, Kimmig D, et al. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood 1999; 93: 694-702
59. Bonecchi R, Facchetti F, Dusi S, et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 2000 Apr; 164 (7): 3862-9
60. Harrison AM, Bonville CA, Rosenberg HF, et al. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999; 159: 1918-24
61. Jaovisidha P, Peeples ME, Brees AA, et al. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol 1999; 163: 2816-20
62. Michel O, Kips J, Duchateau J, et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641-6
63. Pesci A, Balbi B, Malori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998; 12: 380-6
64. Peleman RA, Rytila PH, Kips JC, et al. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 839-43
65. Nocker RE, Schoonbrood DF, van de Graaf EA, et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996; 109: 183-91
66. Keman S. Willemse B, Tollerud DJ, et al. Blood interleukin-8 production is increased in chemical workers with bronchitic symptoms. Am J Ind Med 1997; 32: 670-3
67. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349-55
68. Whittaker AJ, Spiro SG. Inhaled steroid therapy in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000; 6: 104-9
69. Loppow D, Schleiss MB, Kanniess F, et al. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001 Feb; 95 (2): 115-21
70. Bernard GR, Artigas A, Brigham KL, dt al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24
71. Petty TL. The acute respiratory distress syndrome. Historic perspective. Chest 1994; 105 Suppl. 3: 44S-7S
72. Donnelly SC, Haslett C. Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome. Thorax 1992; 47: 260-3
73. Pittet D, Harbarth S, Suter PM, et al. Impact of immunomodulating therapy on morbidity in patients with severe sepsis. Am J Respir Crit Care Med 1999; 160: 852-7
74. Reinhart K, Menges T, Gardlund B, et al. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyper-inflammatory response during severe sepsis. The RAMSES Study. Crit Care Med 2001: 29: 765-9
75. Abraham E, Laterre PF, Garbino J, et al. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med 2001; 29: 503-10
76. Ikuta N, Taniguchi H, Kondoh Y, et al. Sustained high levels of circulatory interleukin-8 are associated with a poor outcome in patients with adult respiratory distress syndrome. Intern Med 1996; 35: 855-60
77. Sekido N, Mukaida N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993; 365: 654-7
78. Brigham KL, Bowers R, Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 1979; 45: 292-7
79. Johnson A, Malik AB. Effect of granulocytopenia on extravascular lung water content after microembolization. Am Rev Respir Dis 1980; 122: 561-6
80. Reid PT, Donnelly SC, Haslett C. Inflammatory predictors for the development of the adult respiratory distress syndrome. Thorax 1995; 50: 1023-6
81. Kurdowska A, Noble JM, Steinberg KP, et al. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Am J Respir Crit Care Med 2001; 163: 463-8
82. Kurdowska A, Carr FK, Stevens MD, et al. Studies on the interaction of IL-8 with human plasma alpha 2-macroglobulin: evidence for the presence of IL-8 complexed to alpha 2-macroglobulin in lung fluids of patients with adult respiratory distress syndrome. J Immunol 1997; 158: 1930-40
83. Kurdowska A, Fujisawa N, Peterson B, et al. Specific binding of IL-8 to rabbit alpha-macroglobulin modulates IL-8 function in the lung. Inflamm Res 2000; 49: 591-9
84. Modi WS, Yoshimura T. Isolation of novel GRO genes and a phylogenetic analysis ofthe CXC chemokine subfamily in mammals. Mol Biol Evol 1999; 16: 180-93
85. White JR, Lee JM, Young PR, et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 1998; 273: 10095-8